| (-)-epigallocatechin 3-gallate | increases phosphorylation | ISO | RGD:731783 | 6480464 | epigallocatechin gallate results in increased phosphorylation of GSK3A protein | CTD | PMID:16968065 |
| (S)-nicotine | multiple interactions | ISO | RGD:731783 | 6480464 | [Nicotine results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of GSK3A protein | CTD | PMID:12511591 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of GSK3A mRNA | CTD | PMID:21346803 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | ISO | RGD:731783 | 6480464 | [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of GSK3A protein | CTD | PMID:12511591 |
| all-trans-retinoic acid | decreases phosphorylation | ISO | RGD:1618666 | 6480464 | Tretinoin results in decreased phosphorylation of GSK3A protein | CTD | PMID:16288212 |
| all-trans-retinoic acid | increases phosphorylation | ISO | RGD:1618666 | 6480464 | Tretinoin results in increased phosphorylation of GSK3A protein | CTD | PMID:16288212 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of GSK3A mRNA | CTD | PMID:16483693 |
| amphetamine | increases response to substance | ISO | RGD:1618666 | 6480464 | GSK3A gene mutant form results in increased susceptibility to Amphetamine | CTD | PMID:20357757 |
| amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of GSK3A protein | CTD | PMID:16144542 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1618666 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of GSK3A mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | GSK3A protein affects the reaction [Benzo(a)pyrene results in decreased expression of MYC protein]; more ... | CTD | PMID:22100782 |
| benzo[a]pyrene | affects response to substance | EXP | | 6480464 | GSK3A protein affects the susceptibility to Benzo(a)pyrene | CTD | PMID:22100782 |
| cisplatin | decreases phosphorylation | ISO | RGD:731783 | 6480464 | Cisplatin results in decreased phosphorylation of GSK3A protein | CTD | PMID:21821001 |
| clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of GSK3A protein | CTD | PMID:16144542 |
| clozapine | multiple interactions | EXP | | 6480464 | DRD2 protein affects the reaction [Clozapine results in increased expression of GSK3A protein] | CTD | PMID:16144542 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of GSK3A mRNA | CTD | PMID:12117546 |
| cyclosporin A | increases phosphorylation | ISO | RGD:1618666 | 6480464 | Cyclosporine results in increased phosphorylation of GSK3A protein | CTD | PMID:22416070 |
| cyclosporin A | increases phosphorylation | ISO | RGD:731783 | 6480464 | Cyclosporine results in increased phosphorylation of GSK3A protein | CTD | PMID:22416070 |
| cyclosporin A | multiple interactions | ISO | RGD:731783 | 6480464 | [GSK3A protein co-treated with GSK3B protein] affects the reaction [Cyclosporine results in increased expression of SNAI1 protein] | CTD | PMID:22416070 |
| elemental selenium | increases expression | ISO | RGD:731783 | 6480464 | Selenium results in increased expression of GSK3A mRNA | CTD | PMID:19244175 |
| haloperidol | increases expression | EXP | | 6480464 | Haloperidol results in increased expression of GSK3A protein | CTD | PMID:16144542 |
| haloperidol | multiple interactions | EXP | | 6480464 | DRD2 protein affects the reaction [Haloperidol results in increased expression of GSK3A protein] | CTD | PMID:16144542 |
| lithium atom | increases expression | EXP | | 6480464 | Lithium results in increased expression of GSK3A protein | CTD | PMID:18296634 |
| lithium atom | multiple interactions | ISO | RGD:731783 | 6480464 | Lithium promotes the reaction [sodium arsenite results in increased phosphorylation of GSK3A protein] | CTD | PMID:17849503 |
| LY294002 | decreases phosphorylation | ISO | RGD:731783 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3A protein | CTD | PMID:21821001 |
| LY294002 | multiple interactions | ISO | RGD:731783 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of GSK3A protein] | CTD | PMID:14750165 |
| LY294002 | decreases phosphorylation | ISO | RGD:1618666 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of GSK3A protein | CTD | PMID:16179367 |
| LY294002 | multiple interactions | ISO | RGD:731783 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of and results in increased activity of GSK3A protein | CTD | PMID:19661225 |
| methamphetamine | decreases expression | ISO | RGD:1618666 | 6480464 | Methamphetamine results in decreased expression of GSK3A protein | CTD | PMID:16192988 |
| paraquat | affects expression | EXP | | 6480464 | Paraquat affects the expression of GSK3A mRNA | CTD | PMID:15206577 |
| phorbol 13-acetate 12-myristate | increases phosphorylation | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased phosphorylation of GSK3A protein | CTD | PMID:17993264 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of GSK3A protein] | CTD | PMID:17993264 |
| prostaglandin E2 | increases phosphorylation | ISO | RGD:1618666 | 6480464 | Dinoprostone results in increased phosphorylation of GSK3A protein | CTD | PMID:20578217 |
| quercetin | decreases expression | ISO | RGD:731783 | 6480464 | Quercetin results in decreased expression of GSK3A protein | CTD | PMID:16968065 |
| resveratrol | multiple interactions | ISO | RGD:731783 | 6480464 | resveratrol results in decreased phosphorylation of and results in increased activity of GSK3A protein | CTD | PMID:17486135 |
| resveratrol | increases phosphorylation | ISO | RGD:731783 | 6480464 | resveratrol results in increased phosphorylation of GSK3A protein | CTD | PMID:14750165 |
| resveratrol | multiple interactions | ISO | RGD:731783 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of GSK3A protein] | CTD | PMID:14750165 |
| resveratrol | decreases phosphorylation | ISO | RGD:731783 | 6480464 | resveratrol results in decreased phosphorylation of GSK3A protein | CTD | PMID:14750165 |
| risperidone | increases expression | EXP | | 6480464 | Risperidone results in increased expression of GSK3A protein | CTD | PMID:16144542 |
| risperidone | multiple interactions | EXP | | 6480464 | DRD2 protein affects the reaction [Risperidone results in increased expression of GSK3A protein] | CTD | PMID:16144542 |
| ruthenium atom | decreases activity | ISO | RGD:731783 | 6480464 | Ruthenium results in decreased activity of GSK3A protein | CTD | PMID:17210701 |
| selenium atom | increases expression | ISO | RGD:731783 | 6480464 | Selenium results in increased expression of GSK3A mRNA | CTD | PMID:19244175 |
| sucrose | decreases phosphorylation | EXP | | 6480464 | Sucrose results in decreased phosphorylation of GSK3A protein | CTD | PMID:12514263 |
| tacrolimus hydrate | multiple interactions | ISO | RGD:731783 | 6480464 | [GSK3A protein co-treated with GSK3B protein] affects the reaction [Tacrolimus results in increased expression of SNAI1 protein] | CTD | PMID:22416070 |
| tacrolimus hydrate | increases phosphorylation | ISO | RGD:731783 | 6480464 | Tacrolimus results in increased phosphorylation of GSK3A protein | CTD | PMID:22416070 |
| trans-resveratrol | multiple interactions | ISO | RGD:731783 | 6480464 | resveratrol results in decreased phosphorylation of and results in increased activity of GSK3A protein | CTD | PMID:17486135 |
| trans-resveratrol | decreases phosphorylation | ISO | RGD:731783 | 6480464 | resveratrol results in decreased phosphorylation of GSK3A protein | CTD | PMID:14750165 |
| trans-resveratrol | multiple interactions | ISO | RGD:731783 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of GSK3A protein] | CTD | PMID:14750165 |
| trans-resveratrol | increases phosphorylation | ISO | RGD:731783 | 6480464 | resveratrol results in increased phosphorylation of GSK3A protein | CTD | PMID:14750165 |